SG151103A1 - Remedy - Google Patents
RemedyInfo
- Publication number
- SG151103A1 SG151103A1 SG200700557-2A SG2007005572A SG151103A1 SG 151103 A1 SG151103 A1 SG 151103A1 SG 2007005572 A SG2007005572 A SG 2007005572A SG 151103 A1 SG151103 A1 SG 151103A1
- Authority
- SG
- Singapore
- Prior art keywords
- macrophages
- remedy
- exterminated
- pathogen
- dysfunction
- Prior art date
Links
- 210000002540 macrophage Anatomy 0.000 abstract 7
- 230000004064 dysfunction Effects 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 206010057249 Phagocytosis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000000242 pagocytic effect Effects 0.000 abstract 1
- 230000008782 phagocytosis Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002247871 | 2002-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG151103A1 true SG151103A1 (en) | 2009-04-30 |
Family
ID=31972490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200700557-2A SG151103A1 (en) | 2002-08-27 | 2003-08-27 | Remedy |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US20060105048A1 (pl) |
| EP (2) | EP1547615B1 (pl) |
| JP (1) | JP3947999B2 (pl) |
| KR (3) | KR101067971B1 (pl) |
| CN (4) | CN1935155A (pl) |
| AU (1) | AU2003261768B2 (pl) |
| BR (1) | BR0313881A (pl) |
| CA (2) | CA2496902C (pl) |
| DK (1) | DK1547615T3 (pl) |
| EA (1) | EA008107B1 (pl) |
| ES (1) | ES2575534T3 (pl) |
| HK (1) | HK1145463A1 (pl) |
| HU (1) | HUE030275T2 (pl) |
| MX (1) | MXPA05002209A (pl) |
| PL (3) | PL375585A1 (pl) |
| SG (1) | SG151103A1 (pl) |
| UA (1) | UA84276C2 (pl) |
| WO (1) | WO2004019982A1 (pl) |
| ZA (1) | ZA200502452B (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007284362A (ja) * | 2006-04-13 | 2007-11-01 | Tokyo Univ Of Science | 薬物送達粒子及びその製造方法 |
| EA016540B1 (ru) * | 2008-12-30 | 2012-05-30 | Ооо "Научно-Производственный Комплекс "Наносистема" | Фармацевтическая композиция для лечения туберкулеза, способ ее получения и способ лечения туберкулеза |
| EP2489270A4 (en) * | 2009-09-28 | 2013-06-26 | Genichiro Soma | PLANT BREEDING AGENT, RESISTANCE INDUCTOR FOR PLANT HARVEST AND METHOD OF COMBATING PLANT HAZARD |
| US8802433B2 (en) | 2009-12-03 | 2014-08-12 | Aureo Co., Ltd. | Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages |
| CN105530953A (zh) * | 2013-10-03 | 2016-04-27 | 日东电工株式会社 | 注射疫苗组合物 |
| WO2017097876A1 (en) * | 2015-12-08 | 2017-06-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for expanding a population of alveolar macrophages in a long term culture |
| CN110945058A (zh) * | 2017-07-27 | 2020-03-31 | 株式会社三养生物制药 | 可生物降解的聚合物微粒的制备方法和由此制备的可生物降解的聚合物微粒 |
| KR200490892Y1 (ko) | 2019-02-26 | 2020-01-17 | 주식회사 남현 | 체압 연동형 의자 등받이 경사 조절기구 |
| KR102210240B1 (ko) | 2020-01-15 | 2021-02-01 | 주식회사 남현 | 탄성력 조절이 가능한 의자 등받이 경사 조절기구 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1739064A (en) * | 1922-12-29 | 1929-12-10 | Ind Waste Products Corp | Process for the manufacture of a sugar product |
| DE69126183D1 (de) * | 1990-08-20 | 1997-06-26 | Den Ichi Mizuno | LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente |
| US5759583A (en) * | 1995-08-30 | 1998-06-02 | Syntex (U.S.A.) Inc. | Sustained release poly (lactic/glycolic) matrices |
| US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| CA2271750C (en) * | 1997-07-02 | 2004-04-27 | Euro-Celtique, S.A. | Prolonged anesthesia in joints and body spaces |
| JP4204085B2 (ja) * | 1997-10-08 | 2009-01-07 | オリジナル・イメージ株式会社 | マクロファージ活性化剤 |
| DE69929904T2 (de) * | 1998-11-18 | 2006-08-31 | University Of Florida, Gainesville | Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen |
| JP4580479B2 (ja) * | 1998-12-21 | 2010-11-10 | 株式会社林原生物化学研究所 | 抗ｈｉｖ感染症剤 |
| US6406745B1 (en) * | 1999-06-07 | 2002-06-18 | Nanosphere, Inc. | Methods for coating particles and particles produced thereby |
| JP2002247871A (ja) | 2001-02-15 | 2002-08-30 | Matsushita Electric Ind Co Ltd | モータ制御装置及びモータ制御方法 |
-
2003
- 2003-08-27 AU AU2003261768A patent/AU2003261768B2/en not_active Ceased
- 2003-08-27 CA CA2496902A patent/CA2496902C/en not_active Expired - Fee Related
- 2003-08-27 PL PL03375585A patent/PL375585A1/pl not_active IP Right Cessation
- 2003-08-27 SG SG200700557-2A patent/SG151103A1/en unknown
- 2003-08-27 CN CNA200610114924XA patent/CN1935155A/zh active Pending
- 2003-08-27 JP JP2004532735A patent/JP3947999B2/ja not_active Expired - Fee Related
- 2003-08-27 CN CNA2006101149254A patent/CN1935156A/zh active Pending
- 2003-08-27 KR KR1020057003529A patent/KR101067971B1/ko not_active IP Right Cessation
- 2003-08-27 PL PL397022A patent/PL397022A1/pl not_active Application Discontinuation
- 2003-08-27 KR KR1020107026831A patent/KR20110002877A/ko not_active Application Discontinuation
- 2003-08-27 CA CA2706622A patent/CA2706622C/en not_active Expired - Fee Related
- 2003-08-27 DK DK03791347.2T patent/DK1547615T3/en active
- 2003-08-27 MX MXPA05002209A patent/MXPA05002209A/es active IP Right Grant
- 2003-08-27 KR KR1020107026830A patent/KR20110002876A/ko not_active Application Discontinuation
- 2003-08-27 CN CN2010101681488A patent/CN101862456B/zh not_active Expired - Fee Related
- 2003-08-27 WO PCT/JP2003/010871 patent/WO2004019982A1/ja active Application Filing
- 2003-08-27 PL PL397023A patent/PL397023A1/pl unknown
- 2003-08-27 ES ES03791347.2T patent/ES2575534T3/es not_active Expired - Lifetime
- 2003-08-27 EP EP03791347.2A patent/EP1547615B1/en not_active Expired - Lifetime
- 2003-08-27 BR BR0313881-0A patent/BR0313881A/pt not_active IP Right Cessation
- 2003-08-27 CN CNA038203278A patent/CN1678350A/zh active Pending
- 2003-08-27 HU HUE03791347A patent/HUE030275T2/en unknown
- 2003-08-27 US US10/525,964 patent/US20060105048A1/en not_active Abandoned
- 2003-08-27 UA UAA200502820A patent/UA84276C2/uk unknown
- 2003-08-27 EP EP11000496A patent/EP2343072A1/en not_active Withdrawn
- 2003-08-27 EA EA200500418A patent/EA008107B1/ru not_active IP Right Cessation
-
2005
- 2005-03-24 ZA ZA200502452A patent/ZA200502452B/en unknown
-
2010
- 2010-03-22 US US12/659,796 patent/US8425939B2/en not_active Expired - Fee Related
- 2010-12-23 HK HK10112021.6A patent/HK1145463A1/xx not_active IP Right Cessation
-
2013
- 2013-03-14 US US13/831,439 patent/US20130202663A1/en not_active Abandoned
-
2014
- 2014-03-21 US US14/221,606 patent/US20140206641A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USD822599S1 (en) | Portable power bank | |
| UY28258A1 (es) | Tratamiento terapeutico | |
| TW200511992A (en) | Sulfonamide substituted imidazoquinolines | |
| PA8588601A1 (es) | Administracion combinada de una indolinona junto a un agente quimioterapeutico para el tratamiento de enfermedades de proliferacion celular | |
| CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
| CA119221S (en) | Blister package | |
| DE60327103D1 (de) | Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer | |
| WO2005039630A3 (en) | Immunogenic compositions | |
| SG151103A1 (en) | Remedy | |
| USD839822S1 (en) | Multifunctional portable power source | |
| CA107279S (en) | Foot/ankle brace | |
| TNSN05330A1 (en) | Tablet comprising fluvastatin and carmellose calcium | |
| PL1713438T3 (pl) | Mydło lecznicze | |
| ITMI20020630A0 (it) | Procedimento per l'esecuzione di una sacca in un manufatto tubolare particolarmente per l'esecuzione del tallone o della punta di calze con | |
| CA179403S (en) | Orthopedic brace | |
| HRP20040186B1 (en) | Use of lhrh-antagonists for the improvement of t-cell mediated immunity | |
| AU2003255287A1 (en) | Use of a proteasome inhibitor in the treatment of fibrotic diseases | |
| CA97550S (en) | Golf bag | |
| MX2007004040A (es) | Uso para alfa-simpatomimeticos con estructura de 2-imidazolina. | |
| CA104374S (en) | Electrical jack | |
| CA104435S (en) | High-chair | |
| AU301383S (en) | A loudspeaker unit | |
| HN2003000067A (es) | Lapiz de yema | |
| CA105222S (en) | Lavatory device | |
| CA96645S (en) | Foot for an article of furniture |